Cervicovaginal matrix metalloproteinase-9 and cervical ripening in human term parturition

Eur J Obstet Gynecol Reprod Biol. 2009 Jan;142(1):43-7. doi: 10.1016/j.ejogrb.2008.08.009. Epub 2008 Nov 18.

Abstract

Objective: To investigate the changes of matrix metalloproteinase-9 (MMP-9) in cervicovaginal fluid during pregnancy and its association with parturition.

Study design: A prospective study was conducted on nulliparous women between 16 and 42 weeks with normal singleton pregnancies in the following categories: (1) preterm control (n=39); (2) term labor induction without labor or rupture of membranes (n=68); (3) term spontaneous labor with intact membranes (n=42); (4) term premature rupture of membranes (n=24). The MMP-9 concentration in the cervicovaginal fluid was measured by immunoassay.

Results: (1) Cervicovaginal MMP-9 did not change significantly with advancing gestation until 37 weeks, and significantly increased after 37 weeks. (2) Cervicovaginal MMP-9 levels were similar in women with no labor, spontaneous labor, and premature rupture of membranes at term. (3) For the induced labor group, a high Bishop score (>or=4) was significantly correlated with cervicovaginal MMP-9. However, an elevated cervicovaginal MMP-9 did not predict achieving active phase of labor or vaginal delivery after labor induction.

Conclusion: Cervicovaginal MMP-9 correlated with cervical ripening before labor at term. However, cervicovaginal MMP-9 did not change with spontaneous labor or rupture of membranes at term and did not predict success of labor induction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Body Fluids / enzymology
  • Cervical Ripening / physiology*
  • Cervix Uteri / enzymology
  • Female
  • Fetal Membranes, Premature Rupture / enzymology
  • Gestational Age
  • Humans
  • Matrix Metalloproteinase 9 / metabolism*
  • Parturition / physiology*
  • Pregnancy
  • Vagina / enzymology

Substances

  • Matrix Metalloproteinase 9